Product Wiki · Recalls · Health Canada — Medical Devices

BRILLIANCE CT AND INGENUITY CT SYSTEM (2015-09-17) — recall 54299

Health Canada — Medical Devices · Canada · 2015-10-08 · Type II

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
54299
Date of alert
2015-10-08
Country / jurisdiction
Canada
Risk level
Type II
Risk type
recall
Product category
Medical devices
Product type
Medical devices
Notice status
Archived by the issuing authority — kept for reference
Reported risk: Issue 1: Image Position Accuracy - Image Rotation Calibration Program performed by field service representative can report pass but fail to produce the correct angular rotation offset value for the ultra-fast scan mode. The inaccurate angular rotation offset can impact the accuracy of radiation treatment planning. Issue 2: Tracker Image Artifact - tracker scan image of CT Angiography (CTA) examination can exhibit a streaking artifact. Due to the streaking artifact, the automatic clinical scan may be triggered at the wrong time resulting in suboptimal CT diagnostic images that do not capture the bolus peak of the imaged body section. Issue 3: Ring/Dot Image Artifact Due to X-ray Measurement - after a complete system power shutdown and power up, if a head scan is performed without air calibration and without quick IQ check scan after power up, intermittent ring/dot image artifacts in the reconstructed images may occur.
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/brilliance-ct-and-ingenuity-ct

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.